Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1982-2025

UROSKOP Omnia Max. Recall

UROSKOP Omnia Max. Model Number: 10762473

FDA recall Class II

Ongoing

FDA lists this Class II recall for UROSKOP Omnia Max.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1982-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 4, 2025
FDA report date
Jun 25, 2025
Quantity in commerce
25 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

UROSKOP Omnia Max. Model Number: 10762473

Affected model & UDI checker

Search the exact identifiers published for Z-1982-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
10762473UROSKOP Omnia Max.Check source noticeNot specified
Not specifiedUROSKOP Omnia Max.Check source notice04056869008981
FDA code information

Model Number: 10762473. UDI Numbers: (01)04056869008981(21)4014, (01)04056869008981(21)4056, (01)04056869008981(21)4049, (01)04056869008981(21)4015, (01)04056869008981(21)4063, (01)04056869008981(21)4022, (01)04056869008981(21)4036, (01)04056869008981(21)4043, (01)04056869008981(21)4024, (01)04056869008981(21)4059, (01)04056869008981(21)4020, (01)04056869008981(21)4032, (01)04056869008981(21)4053, (01)04056869008981(21)4061, (01)04056869008981(21)4060, (01)04056869008981(21)4051, (01)04056869008981(21)4025, (01)04056869008981(21)4037, (01)04056869008981(21)4054, (01)04056869008981(21)4042, (01)04056869008981(21)4033, (01)04056869008981(21)4055, (01)04056869008981(21)4052, (01)04056869008981(21)4047, (01)04056869008981(21)4062. Serial Numbers: 4014, 4056, 4049, 4015, 4063, 4022, 4036, 4043, 4024, 4059, 4020, 4032, 4053, 4061, 4060, 4051, 4025, 4037, 4054, 4042, 4033, 4055, 4052, 4047, 4062.

View the original FDA recall notice

Why was this product recalled?

A resistor in the frequency inverter may strongly overheat potentially igniting the plastic housing of the frequency inverter on fire.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Siemens Medical Solutions USA, Inc. take?

Siemens notified consignees on about 06/04/2025 via letter. Consignees were instructed that they can continue to use their system when paying attention for signs of burning smell and/or smoke coming from the device base. In this case, the system must be immediately disconnected from power supply via room emergency on/off switch and the Siemens Healthineers Service Organization must be informed. Siemens Healthineers is preparing an on-site field safety corrective action to replace the frequency inverter by another type that cannot cause the described problem. The field safety corrective action will be implemented in the second quarter of 2025 with update XP008/25/S and will be provided to you free of charge. Consignees were instructed to ensure that all affected personnel are informed as well as any customers if the unit was further distributed and to acknowledge receipt of the recall notification.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology